These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 26360914)

  • 21. Telomere length abnormalities and telomerase RNA component expression in gastroenteropancreatic neuroendocrine tumors.
    Kim HS; Lee HS; Nam KH; Choi J; Kim WH
    Anticancer Res; 2015 Jun; 35(6):3501-10. PubMed ID: 26026117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Site- and grade-specific diversity of LINE1 methylation pattern in gastroenteropancreatic neuroendocrine tumours.
    Stricker I; Tzivras D; Nambiar S; Wulf J; Liffers ST; Vogt M; Verdoodt B; Tannapfel A; Mirmohammadsadegh A
    Anticancer Res; 2012 Sep; 32(9):3699-706. PubMed ID: 22993308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Comprehensive Assessment of the Role of miRNAs as Biomarkers in Gastroenteropancreatic Neuroendocrine Tumors.
    Malczewska A; Kidd M; Matar S; Kos-Kudla B; Modlin IM
    Neuroendocrinology; 2018; 107(1):73-90. PubMed ID: 29566385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular and cell biological aspects of neuroendocrine tumors of the gastroenteropancreatic system.
    Wiedenmann B; John M; Ahnert-Hilger G; Riecken EO
    J Mol Med (Berl); 1998 Aug; 76(9):637-47. PubMed ID: 9725766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetics and molecular pathology of neuroendocrine gastrointestinal and pancreatic tumors (gastroenteropancreatic neuroendocrine tumors).
    Oberg K
    Curr Opin Endocrinol Diabetes Obes; 2009 Feb; 16(1):72-8. PubMed ID: 19115524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of molecular pathways in sporadic neuroendocrine tumors of the gastro-entero-pancreatic system.
    Arnold CN; Sosnowski A; Schmitt-Gräff A; Arnold R; Blum HE
    Int J Cancer; 2007 May; 120(10):2157-64. PubMed ID: 17278096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinct genome-wide methylation patterns in sporadic and hereditary nonfunctioning pancreatic neuroendocrine tumors.
    Tirosh A; Mukherjee S; Lack J; Gara SK; Wang S; Quezado MM; Keutgen XM; Wu X; Cam M; Kumar S; Patel D; Nilubol N; Tyagi MV; Kebebew E
    Cancer; 2019 Apr; 125(8):1247-1257. PubMed ID: 30620390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Subset of Large Cell Neuroendocrine Carcinomas in the Gastroenteropancreatic Tract May Evolve from Pre-existing Well-Differentiated Neuroendocrine Tumors.
    Pelosi G; Bianchi F; Dama E; Metovic J; Barella M; Sonzogni A; Albini A; Papotti M; Gong Y; Vijayvergia N
    Endocr Pathol; 2021 Sep; 32(3):396-407. PubMed ID: 33433886
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of molecular pathways in neuroendocrine cancers of the gastroenteropancreatic system.
    Arnold CN; Sosnowski A; Blum HE
    Ann N Y Acad Sci; 2004 Apr; 1014():218-9. PubMed ID: 15153437
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genome Methylation Accurately Predicts Neuroendocrine Tumor Origin: An Online Tool.
    Hackeng WM; Dreijerink KMA; de Leng WWJ; Morsink FHM; Valk GD; Vriens MR; Offerhaus GJA; Geisenberger C; Brosens LAA
    Clin Cancer Res; 2021 Mar; 27(5):1341-1350. PubMed ID: 33355250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Cross-Species Analysis in Pancreatic Neuroendocrine Tumors Reveals Molecular Subtypes with Distinctive Clinical, Metastatic, Developmental, and Metabolic Characteristics.
    Sadanandam A; Wullschleger S; Lyssiotis CA; Grötzinger C; Barbi S; Bersani S; Körner J; Wafy I; Mafficini A; Lawlor RT; Simbolo M; Asara JM; Bläker H; Cantley LC; Wiedenmann B; Scarpa A; Hanahan D
    Cancer Discov; 2015 Dec; 5(12):1296-313. PubMed ID: 26446169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Endoscopic diagnosis of gastroenteropancreatic neuroendocrine tumors].
    López-Jamar JM
    Endocrinol Nutr; 2009 Sep; 56 Suppl 3():8-13. PubMed ID: 20542214
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epigenetic changes in gastroenteropancreatic neuroendocrine tumours.
    Mapelli P; Aboagye EO; Stebbing J; Sharma R
    Oncogene; 2015 Aug; 34(34):4439-47. PubMed ID: 25435371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular genetics of gastroenteropancreatic neuroendocrine tumors.
    Starker LF; Carling T
    Curr Opin Oncol; 2009 Jan; 21(1):29-33. PubMed ID: 19125015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic Impact of Novel Molecular Subtypes of Small Intestinal Neuroendocrine Tumor.
    Karpathakis A; Dibra H; Pipinikas C; Feber A; Morris T; Francis J; Oukrif D; Mandair D; Pericleous M; Mohmaduvesh M; Serra S; Ogunbiyi O; Novelli M; Luong T; Asa SL; Kulke M; Toumpanakis C; Meyer T; Caplin M; Meyerson M; Beck S; Thirlwell C
    Clin Cancer Res; 2016 Jan; 22(1):250-8. PubMed ID: 26169971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
    de Herder WW
    Best Pract Res Clin Gastroenterol; 2012 Dec; 26(6):689-90. PubMed ID: 23582912
    [No Abstract]   [Full Text] [Related]  

  • 37. Identification of sequence polymorphisms in the displacement loop region of mitochondrial DNA as a risk factor for gastroenteropancreatic neuroendocrine neoplasm.
    Er LM; Wu ML; Gao Y; Wang SJ; Li Y
    J Clin Lab Anal; 2017 Sep; 31(5):. PubMed ID: 27704598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinct DNA Methylation Signatures in Neuroendocrine Tumors Specific for Primary Site and Inherited Predisposition.
    Tirosh A; Killian JK; Petersen D; Zhu YJ; Walker RL; Blau JE; Nilubol N; Patel D; Agarwal SK; Weinstein LS; Meltzer P; Kebebew E
    J Clin Endocrinol Metab; 2020 Oct; 105(10):3285-94. PubMed ID: 32706863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular genetics of gastroenteropancreatic neuroendocrine tumors.
    Toumpanakis CG; Caplin ME
    Am J Gastroenterol; 2008 Mar; 103(3):729-32. PubMed ID: 18341492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The landscape of molecular alterations in pancreatic and small intestinal neuroendocrine tumours.
    Scarpa A
    Ann Endocrinol (Paris); 2019 Jun; 80(3):153-158. PubMed ID: 31072588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.